{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-24-000061","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2024-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.171830+00:00","generated_at":"2026-05-31T21:58:43.382630+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Edwards Lifesciences appoints David T. Feinberg to Board, effective July 10","bullets":["David T. Feinberg, M.D. appointed to Edwards Lifesciences Board and Audit Committee, effective July 10, 2024.","Dr. Feinberg is Chairman of Oracle Health, former CEO of Cerner (acquired by Oracle in 2022).","Previously held leadership roles at Google Health, Geisinger Health, and UCLA Health.","Will receive standard non-employee director compensation per 2024 Proxy and standard indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-24-000061","json":"https://secwatch.observer/filing/0001099800-24-000061.json","markdown":"https://secwatch.observer/filing/0001099800-24-000061.md","text":"https://secwatch.observer/filing/0001099800-24-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000061/0001099800-24-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000061/ew-20240710.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:58:43.382630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58c1956504","claim":"David T. Feinberg was appointed as Director at Edwards Lifesciences Corp.","evidence_excerpt":"On July 10, 2024, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), appointed David T. Feinberg, M.D. to the Company’s Board of Directors (the “Board”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000061/0001099800-24-000061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}